Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Comparing dried blood spots and plasma concentrations for busulfan therapeutic drug monitoring in children.

Ana D, Youssef D, Jules D, Yves C, Chakradhara Rao Satyanarayana U, Marc A.

Ther Drug Monit. 2019 Jul 24. doi: 10.1097/FTD.0000000000000673. [Epub ahead of print]

PMID:
31348116
2.

Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.

Nava T, Kassir N, Rezgui MA, Uppugunduri CRS, Huezo-Diaz Curtis P, Duval M, Théoret Y, Daudt LE, Litalien C, Ansari M, Krajinovic M, Bittencourt H.

Br J Clin Pharmacol. 2018 Jul;84(7):1494-1504. doi: 10.1111/bcp.13566. Epub 2018 Apr 27.

3.

Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance.

Choong E, Uppugunduri CRS, Marino D, Kuntzinger M, Doffey-Lazeyras F, Lo Piccolo R, Chalandon Y, Peters C, Daali Y, Ansari M.

Ther Drug Monit. 2018 Feb;40(1):84-92. doi: 10.1097/FTD.0000000000000468. Erratum in: Ther Drug Monit. 2018 Apr;40(2):284.

PMID:
29189665
4.

Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use.

Mlakar V, Huezo-Diaz Curtis P, Satyanarayana Uppugunduri CR, Krajinovic M, Ansari M.

Int J Mol Sci. 2016 Sep 8;17(9). pii: E1502. doi: 10.3390/ijms17091502. Review.

5.

Relative Copy Number Variations of CYP2C19 in South Indian Population.

Devendran A, Uppugunduri CR, Sundaram R, Shewade DG, Rajagopal K, Chandrasekaran A.

Mol Biol Int. 2012;2012:643856. doi: 10.1155/2012/643856. Epub 2012 Jun 25.

6.

Possible involvement of microRNAs (miR-135a∗) in heart failure associated with 25bp deletion in MYBPC3 (cardiac myosin binding protein C) gene.

Uppugunduri CR.

Med Hypotheses. 2011 Feb;76(2):306. doi: 10.1016/j.mehy.2010.11.032. Epub 2010 Dec 23. No abstract available.

PMID:
21185128

Supplemental Content

Loading ...
Support Center